Qube Research & Technologies Ltd - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$12,491,445
+2316.1%
330,724
+2727.4%
0.07%
+2133.3%
Q3 2022$517,000
-91.7%
11,697
-91.1%
0.00%
-96.6%
Q3 2020$6,245,000
+1076.1%
131,618
+1072.5%
0.09%
+304.5%
Q1 2020$531,000
+53.9%
11,225
+96.3%
0.02%
+100.0%
Q4 2019$345,0005,7170.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bellevue Group AG 9,463,400$418,566,0006.01%
Tweedy, Browne Co LLC 2,722,988$120,438,0005.30%
BVF INC/IL 2,872,953$127,071,0005.25%
Sicart Associates LLC 253,976$11,233,0003.98%
Parkman Healthcare Partners LLC 241,945$10,701,0003.04%
Camber Capital Management LP 1,925,000$85,143,0002.61%
Privium Fund Management B.V. 148,807$6,589,0002.39%
SECTOR GAMMA AS 164,223$7,264,0001.87%
HANSEATIC MANAGEMENT SERVICES INC 10,993$486,0001.31%
BRANDYWINE MANAGERS, LLC 8,460$374,0001.23%
View complete list of IONIS PHARMACEUTICALS INC shareholders